TipRanks
Advertisement
Advertisement
RemeGen Commits US$100 Million of Idle Funds to OCBC Wealth Products in Discloseable Transaction
PremiumCompany AnnouncementsRemeGen Commits US$100 Million of Idle Funds to OCBC Wealth Products in Discloseable Transaction
2M ago
RemeGen Sets Board Meeting to Approve Interim 2026 Results
Premium
Company Announcements
RemeGen Sets Board Meeting to Approve Interim 2026 Results
2M ago
RemeGen Forecasts Major Profit Turnaround on Surging Drug Sales and AbbVie Licensing Deal
Premium
Company Announcements
RemeGen Forecasts Major Profit Turnaround on Surging Drug Sales and AbbVie Licensing Deal
2M ago
RemeGen Wins NMPA Approval for New Telitacicept Indication in Sjögren’s Disease
PremiumCompany AnnouncementsRemeGen Wins NMPA Approval for New Telitacicept Indication in Sjögren’s Disease
4M ago
RemeGen boosts cash management with new RMB300 million SPDB wealth product
Premium
Company Announcements
RemeGen boosts cash management with new RMB300 million SPDB wealth product
4M ago
RemeGen Expands Use of Idle Funds in HTSC Wealth Products
Premium
Company Announcements
RemeGen Expands Use of Idle Funds in HTSC Wealth Products
5M ago
RemeGen Launches Election for Third-Session Board as Current Term Nears Expiry
PremiumCompany AnnouncementsRemeGen Launches Election for Third-Session Board as Current Term Nears Expiry
5M ago
RemeGen Plans Governance and Articles Overhaul Following Share Incentive Issuances
Premium
Company Announcements
RemeGen Plans Governance and Articles Overhaul Following Share Incentive Issuances
5M ago
RemeGen Deploys Idle Cash Into RMB453 Million HTSC Wealth Products
Premium
Company Announcements
RemeGen Deploys Idle Cash Into RMB453 Million HTSC Wealth Products
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―